Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atacicept plus corticosteroids and cyclophosphamide/azathioprine in lupus nephritis
2008-002221-36Phase 2Completed
- Sponsor
- Merck Serono
- Start
- Aug 2008
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in lupus nephritis (LN) comparing Atacicept plus standard therapy with Placebo plus standard therapy (2 arms). Primary endpoint: Complete renal response at Week 52. Started Aug 2008; status: completed.
02
Drugs
atacicept
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on 2008-002221-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002221-36.